HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy.

Abstract
A century after discovering that the Trypanosoma cruzi parasite is the etiological agent of Chagas disease, treatment is still plagued by limited efficacy, toxicity, and the emergence of drug resistance. The development of inhibitors of the major T. cruzi cysteine protease, cruzain, has been demonstrated to be a promising drug discovery avenue for this neglected disease. Here we establish that a nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitor substantially ameliorates symptoms of acute Chagas disease in a mouse model with no apparent toxicity. A high-resolution crystal structure confirmed the mode of inhibition and revealed key binding interactions of this novel inhibitor class. Subsequent structure-guided optimization then resulted in inhibitor analogues with improvements in potency despite minimal or no additions in molecular weight. Evaluation of the analogues in cell culture showed enhanced activity. These results suggest that nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors have the potential to fulfill the urgent need for improved Chagas disease chemotherapy.
AuthorsKatrien Brak, Iain D Kerr, Kimberly T Barrett, Nobuhiro Fuchi, Moumita Debnath, Kenny Ang, Juan C Engel, James H McKerrow, Patricia S Doyle, Linda S Brinen, Jonathan A Ellman
JournalJournal of medicinal chemistry (J Med Chem) Vol. 53 Issue 4 Pg. 1763-73 (Feb 25 2010) ISSN: 1520-4804 [Electronic] United States
PMID20088534 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Ketones
  • Protozoan Proteins
  • Quinolines
  • Triazoles
  • Trypanocidal Agents
  • Cysteine Endopeptidases
  • cruzain, Trypanosoma cruzi
Topics
  • Animals
  • Cattle
  • Cells, Cultured
  • Chagas Disease (drug therapy)
  • Cysteine Endopeptidases
  • Female
  • Ketones (chemical synthesis, chemistry, pharmacology)
  • Macrophages (drug effects, parasitology)
  • Mice
  • Mice, Inbred C3H
  • Models, Molecular
  • Parasitic Sensitivity Tests
  • Protozoan Proteins (antagonists & inhibitors)
  • Quinolines (chemical synthesis, chemistry, pharmacology)
  • Stereoisomerism
  • Structure-Activity Relationship
  • Triazoles (chemical synthesis, chemistry, pharmacology)
  • Trypanocidal Agents (chemical synthesis, chemistry, pharmacology)
  • Trypanosoma cruzi (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: